- Investing Ideas
- Swiss Pharmaceuticals & Biotech Blue chip stocks
Swiss Pharmaceuticals & Biotech Blue chip stocks
Results
3
0 new
3 companies
Sandoz Group
Market Cap: CHF 31.1b
Develops, manufactures, and markets generic and biosimilars worldwide.
SDZ
CHF 71.88
7D
3.5%
1Y
65.5%
Lonza Group
Market Cap: CHF 37.3b
Operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 534.60
7D
6.8%
1Y
-5.4%
Galderma Group
Market Cap: CHF 41.8b
Operates as a dermatology company worldwide.
GALD
CHF 178.25
7D
2.6%
1Y
55.0%